Lynne Cohen Consortium Research Projects

The Lynne Cohen Foundation provided funding for the following MD Anderson Cancer Center studies presented at ASCO (American Society of Clinical Oncologists) 2010:

• The Effects of Oral Contraceptive Use on the Clinicopathological Characteristics of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

• BRCA Mutations in Women with Inflammatory Breast Cancer

• Ethnicity on Genotype-Phenotype Correlations in Individuals with a BRCA1 or BRCA2 Mutation

• Obesity, Smoking, Alcohol and the Risk of Multiple Primary Breast Cancers in BRCA1 and BRCA2 Mutation Carriers

The Lynne Cohen Consortium is currently working on the following collaborative, multi-site research projects:

Decision to Undergo Risk-Reducing Bilateral Salpingo-Oophorectomy in Patients Who Harbor a Gene Mutation of Uncertain Significance
Principal Investigator: Mack Barnes, M.D., University of Alabama, Birmingham

Long-Term Follow-Up of Risk Reducing Bilateral Salpingo-Oophorectomy
Principal Investigator: Stephanie Blank, M.D., NYU Cancer Institute

Improved Survival in Ovarian Cancer Patients with BRCA Mutations
Principal Investigator: Karen, Lu, M.D., MD Anderson Cancer Center

Attitudes About Childbearing And Fertility In Women Seeking Genetic Testing For Inherited Breast And Ovarian Cancer Syndromes (HBOC)
Principal Investigator: Banu Arun, M.D., MD Anderson Cancer Center

Study of the Incidence of BRCA Mutations Unselected Latina/Hispanic Ovarian Cancer Patients
In Partnership With: USC/Norris and LAC+USC Medical Center

Visit the Ways to Give page to sponsor a Lynne Cohen Consortium Research Project focused on early detection and prevention.